Yvonne Schlaeppi - NACD D.C.

Independent Director at OpGen, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Boston

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Biotechnology Research
    • 1 - 100 Employee
    • Independent Director
      • Nov 2022 - Present

      Rockville, Maryland, United States Member, Audit Committee NASDAQ: "OpGen" A precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Curetis GmbH (Germany) and Ares Genetics GmbH (Austria) are subsidiaries.

    • United States
    • Appliances, Electrical, and Electronics Manufacturing
    • 100 - 200 Employee
    • Independent Director (NASDAQ ALOT)
      • 2018 - Present

      Rhode Island, USA Chair, Nominating Committee & Member, Audit Committee NASDAQ: “ALOT” An industrial company which applies data visualization technologies to the design, manufacture, distribution and service of hardware and software products for the aerospace and defense, packaging and product identification, and electronic signal data test and measurement sectors

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Member, External Advisory Council, Channing Division of Network Medicine
      • 2015 - Present

      Boston, USA Strategic and financial planning advice The Channing Division encompasses 300 researchers and staff from the Brigham and other Harvard Medical School-affiliated institutions

    • United States
    • International Trade and Development
    • Managing Partner & Co-Founder
      • 2011 - Present

      Boston, USA Provide strategic advice to tech and life sciences companies on industry alliances, product development, global sales strategies, business expansion, and transactions

    • Switzerland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Independent Director (Euronext Paris STAGR)
      • 2016 - 2019

      London, United Kingdom Special Committee of Independent Directors (Going Private Transaction, closed 5.2019) Audit, Remuneration and Appointments Committees A global healthcare company specializing in the diagnosis and treatment of allergies Stallergenes Greer plc is the parent company of Greer Laboratories, Inc. (U.S.) and Stallergenes S.A.S. (France)

    • Environmental Services
    • Independent Director, Compliance Lead
      • 2014 - 2015

      North Carolina, USA A leading developer and provider of allergy immunotherapy products and services for treating humans and animals; an Ares Life Sciences portfolio company Board disbanded on closing of merger of Greer with Stallergenes

    • Independent Director, Compliance Lead
      • 2014 - 2015

      Delaware, USA Holding for Ares Life Sciences US portfolio in human and animal allergy immunotherapy Board disbanded on closing of merger

    • Qatar
    • IT Services and IT Consulting
    • General Counsel
      • 2007 - 2011

      Greater Boston Area, USA Privately-held high security document printing solutions provider (including passport issuing systems) and systems integrator with global operations and government customers (US, Canada, Middle East, Asia)

    • EVP, General Counsel & Corporate IP Officer
      • 2006 - 2007

      Oss, The Netherlands Pharma (Organon), Biotech and Animal Health (Intervet) with US$ 5+ billion sales; operations in 80 countries; 20,000 employees Sold in 2007 by Akzo Nobel to Schering-Plough on eve of IPO Senior Management Team member. Led legal affairs and IP groups globally

    • United States
    • Retail
    • 1 - 100 Employee
    • Partner & Chair, International Practice Group
      • 1999 - 2006

      Boston, USA Law firm; US$ 305M 2006 revenue; nine offices; 520 attorneys; 120 equity partners Co-Chair of International Practice after 2005 merger with Edwards & Angell Cross-border transactions practice focused on strategic, long-term alliances and joint ventures, mergers and acquisitions, intellectual property licenses; life sciences and information technology industries, including advising Boards and investors

    • Ireland
    • Industrial Machinery Manufacturing
    • 700 & Above Employee
    • General Counsel Europe
      • 1994 - 1998

      Burscheid, Germany Fortune 100 (NYSE: "JCI") Chief Legal Officer and Senior Management Team for Automotive Systems and Plastics Technology Groups Europe (US$ 4B+ sales; 92 plants in 18 countries; 23,000+ employees; 1,500+ suppliers) Extremely rapid growth; cross-border M&A and technology JV's Decision-maker European Counsel (1995-1997)

    • Switzerland
    • International Affairs
    • 1 - 100 Employee
    • Board Member
      • 1986 - 1994

      New York, NY, USA

    • United States
    • Law Practice
    • 700 & Above Employee
    • International Corporate Attorney
      • 1985 - 1994

      New York, NY, USA & Zurich, Switzerland US, European, Middle-Eastern and Latin American publicly- and privately-owned corporate group clients represented in multinational and US acquisitions, restructurings, financings, privatizations, joint ventures, initial public offerings, international arbitrations, anti-bribery investigations and trade sanctions

Education

  • Columbia University in the City of New York
    JD, School of Law
    1982 - 1985
  • The University of Bonn
    German Fulbright Fellowship, DAAD, Awarded by German State Dept.
    1981 - 1982
  • Princeton University
    BA, Woodrow Wilson School of Public & International Affairs
    1977 - 1981

Community

You need to have a working account to view this content. Click here to join now